Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast Cancer.
第一作者:
Ana M,Gonzalez-Angulo
第一单位:
Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX.
作者:
主题词
成年人(Adult);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);化学疗法, 辅助(Chemotherapy, Adjuvant);剂量效应关系, 药物(Dose-Response Relationship, Drug);抗药性, 肿瘤(Drug Resistance, Neoplasm);埃博霉素类(Epothilones);女(雌)性(Female);人类(Humans);中年人(Middle Aged);肿瘤转移(Neoplasm Metastasis)
DOI
10.1016/j.clbc.2015.03.004
PMID
25913905
发布时间
2023-11-11
- 浏览52

Clinical breast cancer
325-31页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文